The Scientific Team at Anokion SA is responsible for conducting cutting-edge research and development to advance the company's mission of restoring immune tolerance in patients with autoimmune diseases. This team collaborates on the design and execution of experiments, analyzes data, and innovates new therapeutic approaches to tackle diseases such as celiac disease, multiple sclerosis, and type 1 diabetes. Their work is crucial in driving the scientific strategy and ensuring that Anokion's treatments are both effective and safe for patients.
Anthony G. Quinn
Scientific Advisor
Burt Adelman
Scientific Advisor
David P. Nowotnik
Scientific Advisor
Dylan Adams
Senior Research Associate
Jeffrey Hubbell
Co-Founder, Chief Scientific A...
Kristie Grebe
Chief Scientific Officer
Madhuri Tilva
Sr. Research Associate II
Vladimir R. Muzykant...
Scientific Advisor
View all